Alkhouri N - Search Results

1

Therapeutic pipeline in nonalcoholic steatohepatitis.

Vuppalanchi R, Noureddin M, Alkhouri N, Sanyal AJ. Vuppalanchi R, et al. Among authors: alkhouri n. Nat Rev Gastroenterol Hepatol. 2021 Jun;18(6):373-392. doi: 10.1038/s41575-020-00408-y. Epub 2021 Feb 10. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33568794 Review.

2

Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal.

Alkhouri N, Dixon LJ, Feldstein AE. Alkhouri N, et al. Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):445-51. doi: 10.1586/egh.09.32. Expert Rev Gastroenterol Hepatol. 2009. PMID: 19673631 Free PMC article. Review.

3

An apoptosis panel for nonalcoholic steatohepatitis diagnosis.

Tamimi TI, Elgouhari HM, Alkhouri N, Yerian LM, Berk MP, Lopez R, Schauer PR, Zein NN, Feldstein AE. Tamimi TI, et al. Among authors: alkhouri n. J Hepatol. 2011 Jun;54(6):1224-9. doi: 10.1016/j.jhep.2010.08.023. Epub 2011 Feb 12. J Hepatol. 2011. PMID: 21145805 Free PMC article.

4

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

Alkhouri N, Carter-Kent C, Feldstein AE. Alkhouri N, et al. Expert Rev Gastroenterol Hepatol. 2011 Apr;5(2):201-12. doi: 10.1586/egh.11.6. Expert Rev Gastroenterol Hepatol. 2011. PMID: 21476915 Free PMC article. Review.

5

Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.

Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L, Zein NN, Feldstein AE. Alkhouri N, et al. Liver Int. 2012 Feb;32(2):297-302. doi: 10.1111/j.1478-3231.2011.02639.x. Epub 2011 Sep 8. Liver Int. 2012. PMID: 22097893

6

Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease.

Alkhouri N, De Vito R, Alisi A, Yerian L, Lopez R, Feldstein AE, Nobili V. Alkhouri N, et al. J Hepatol. 2012 Dec;57(6):1312-8. doi: 10.1016/j.jhep.2012.07.027. Epub 2012 Aug 4. J Hepatol. 2012. PMID: 22871498

7

Novel therapeutic targets for nonalcoholic fatty liver disease.

Eguchi A, Povero D, Alkhouri N, Feldstein AE. Eguchi A, et al. Among authors: alkhouri n. Expert Opin Ther Targets. 2013 Jul;17(7):773-9. doi: 10.1517/14728222.2013.789502. Epub 2013 Apr 22. Expert Opin Ther Targets. 2013. PMID: 23600493 Review.

8

Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children.

Feldstein AE, Alkhouri N, De Vito R, Alisi A, Lopez R, Nobili V. Feldstein AE, et al. Among authors: alkhouri n. Am J Gastroenterol. 2013 Sep;108(9):1526-31. doi: 10.1038/ajg.2013.168. Epub 2013 Jun 11. Am J Gastroenterol. 2013. PMID: 23752877

9

Hematocrit levels and red blood cell indices in patients with nonalcoholic fatty liver disease.

Issa D, Albeldawi M, Lopez R, Alkhouri N. Issa D, et al. Among authors: alkhouri n. Eur J Gastroenterol Hepatol. 2014 Mar;26(3):363-4. doi: 10.1097/MEG.0000000000000031. Eur J Gastroenterol Hepatol. 2014. PMID: 24463543 No abstract available.

10

Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities.

Shaker M, Tabbaa A, Albeldawi M, Alkhouri N. Shaker M, et al. Among authors: alkhouri n. World J Gastroenterol. 2014 May 14;20(18):5320-30. doi: 10.3748/wjg.v20.i18.5320. World J Gastroenterol. 2014. PMID: 24833862 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

259 results

Search Page